Efficacy of continuous midazolam infusion and mortality in childhood refractory generalized convulsive status epilepticus

被引:37
作者
Ozdemir, D [1 ]
Gulez, P
Uran, N
Yendur, G
Kavakli, T
Aydin, A
机构
[1] Dokuz Eylul Univ, Sch Med, Dept Paediat, Izmir, Turkey
[2] Dr Behcet Uz Childrens Hosp, Izmir, Turkey
来源
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY | 2005年 / 14卷 / 02期
关键词
refractory status epilepticus; midazolam; mortality; childhood;
D O I
10.1016/j.seizure.2004.12.005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: Continuous midazolam infusion is commonly used for the management of status epilepticus (SE). The purpose of this study was to assess the efficacy of midazolam and mortality in childhood refractory generalized convulsive SE. Methods: We included 27 children with refractory generalized convulsive SE. Midazolam was given 0.2 mg/kg as bolus, followed by 1-5 mug/kg/min as continuous infusion. Clinical data and response to treatment were recorded for each patient. Results: Acute symptomatic SE accounted for 52%, and central nervous system (CNS) infections were the most frequently associated etiologic condition (44%). Complete control of seizures was achieved with midazolam infusion in the 26 (96%) children within 65 min; at a mean midazolam infusion rate of 3.1 mug/kg/min. Adverse effects such as hypotension, bradycardia or respiratory depression did not occur during midazolam infusion. In one (4%) patient with acute meningoencephalitis, SE could not be controlled. Five (19%) patients died; four had acute symptomatic aetiology and one had progressive encephalopathy. Conclusion: Midazolam is effective and safe in the control of refractory generalized convulsive SE. The response to treatment and mortality were related to the underlying aetiology. (C) 2004 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:129 / 132
页数:4
相关论文
共 18 条
[1]  
Commission on Classification and Terminology of the International League Against Epilepsy, 1989, EPILEPSIA, V30, P389
[2]   Efficacy and mortality in treatment of refractory generalized convulsive status epilepticus in children: A meta-analysis [J].
Gilbert, DL ;
Gartside, PS ;
Glauser, TA .
JOURNAL OF CHILD NEUROLOGY, 1999, 14 (09) :602-609
[3]   Treatment of convulsive status epilepticus with propofol: Case report [J].
Harrison, AM ;
Lugo, RA ;
Schunk, JE .
PEDIATRIC EMERGENCY CARE, 1997, 13 (06) :420-422
[4]   Midazolam and pentobarbital for refractory status epilepticus [J].
Holmes, GL ;
Riviello, JJ .
PEDIATRIC NEUROLOGY, 1999, 20 (04) :259-264
[5]   Midazolam coma for refractory status epilepticus in children [J].
Igartua, J ;
Silver, P ;
Maytal, J ;
Sagy, M .
CRITICAL CARE MEDICINE, 1999, 27 (09) :1982-1985
[6]   Neurologic outcomes of pediatric epileptic patients with pentobarbital coma [J].
Kim, SJ ;
Lee, DY ;
Kim, JS .
PEDIATRIC NEUROLOGY, 2001, 25 (03) :217-220
[7]  
Koul R, 2002, J CHILD NEUROL, V17, P908
[8]   Continuous midazolam infusion as treatment of status epilepticus [J].
Koul, RL ;
Aithala, GR ;
Chacko, A ;
Joshi, R ;
Elbualy, MS .
ARCHIVES OF DISEASE IN CHILDHOOD, 1997, 76 (05) :445-448
[9]   INTRAVENOUS MIDAZOLAM FOR THE TREATMENT OF REFRACTORY STATUS EPILEPTICUS [J].
KUMAR, A ;
BLECK, TP .
CRITICAL CARE MEDICINE, 1992, 20 (04) :483-488
[10]  
MAYTAL J, 1989, PEDIATRICS, V83, P323